Recent Investment Dilon Technologies recently secured a $9 million growth capital investment, indicating strong investor confidence and potential for expanding sales efforts and product development initiatives.

Product Innovation The company has launched advanced medical devices such as the Navigator 2.0 gamma probe system and CoPilot VL+ video laryngoscope, presenting opportunities to promote these innovative solutions to hospitals and surgical centers.

Market Expansion Partnership with Australian Allografts as the exclusive distributor for Navigator 2.0 in Australia highlights potential sales prospects in international markets and collaborative growth opportunities.

Industry Positioning Operating within the medical equipment manufacturing sector with a focus on cancer detection, hemostasis, and airway management, Dilon Technologies serves a specialized niche ideal for targeted outreach to oncology and surgical equipment buyers.

Digital Engagement Utilizing multiple digital tools including Facebook Pixel, WordPress, and analytics platforms, the company is positioned to leverage digital marketing strategies to attract potential clients and expand its customer base.